Eshini Panditharatna

Author

Dana-Farber Cancer Institute ORCID

Also Known As

E. Panditharatna, Eshini Panditharatna

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Children's National Neurological Surgery George Washington University Children's Hospital of Philadelphia

About

Eshini Panditharatna is an author at Dana-Farber Cancer Institute specializing in cell biology, medicine, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	99
2	Cell Biology	2	2	99
3	Pathology	1	1	43
4	Cancer Cell Biology	1	1	56
5	Cancer Genetics	1	1	56

Eshini Panditharatna

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma Hamid Nikbakht, Eshini Panditharatna, Leonie G. Mikael, Nature Communications	2016	255
Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy Eshini Panditharatna, Lindsay Kilburn, Mariam Aboian, Clinical Cancer Research	2018	184
The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location Ilon Liu, Li Jiang, Erik Samuelsson, Nature Genetics	2022	173
A pilot precision medicine trial for children with diffuse intrinsic pontine glioma—PNOC003: A report from the Pacific Pediatric Neuro‐Oncology Consortium Sabine Mueller, Payal Jain, Winnie S. Liang, International Journal of Cancer	2019	127
Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas Justyna M. Przystal, Chiara Cosentino, Sridevi Yadavilli, Neuro-Oncology	2022	91
A Phase I Trial of Imetelstat in Children with Refractory or Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Study (ADVL1112) Patrick A. Thompson, Rachid Drissi, Jodi A. Muscal, Clinical Cancer Research	2013	79
Standardization of the liquid biopsy for pediatric diffuse midline glioma using ddPCR Daphne Li, Erin R. Bonner, Kyle Wierzbicki, Scientific Reports	2021	56
VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system Jonathan So, Nathaniel W. Mabe, Bernhard Englinger, JCI Insight Dna MethylationCell DeathCollateral LethalityCancer BiologyGlioma	2022	56
A standardized autopsy procurement allows for the comprehensive study of DIPG biology Madhuri Kambhampati, Jennifer Pérez, Sridevi Yadavilli, Oncotarget	2015	43
Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas Kathleen Dorris, Matthew Sobo, Arzu Onar‐Thomas, Journal of Neuro-Oncology Neuro-oncologyPediatric Brain TumorsGliomaPathologyHigh-grade Gliomas	2014	43

Page 1